Q podden with CEO Janet Hoogstraate
Janet Hoogstraate, the CEO of NorthX Biologics, recently appeared in an episode of Q-podden, a podcast on manufacturing, quality and corporate culture in life science. Janet discusses the latest trends and ...
Ensuring every child is vaccinated
On behalf of the Swedish Ministry for Foreign Affairs and Gavi, the Global Vaccine Alliance, NorthX Biologics’ CEO Janet Hoogstraate participated in an important roundtable on “Leveraging Technology and Innovation to Ensure Every ...
The rise of the CDMO era – an investor’s perspective
Based on a presentation given by Thomas Eldered at the PharmaOutsourcing event, Stockholm, Sweden, December 2024. From vertical integration to decentralization The pharmaceutical industry has undergone a seismic shift over ...
Q podden with CQO Thomas Beck
Thomas Beck, the Chief Quality Officer (CQO) at NorthX Biologics, was recently featured in an episode of Q podden, a podcast on manufacturing, quality and corporate culture in life science. In ...
Navigating Novo Nordisk’s acquisition of Catalent
In this episode of the Molecule to Market podcast, NorthX Biologics CEO Janet Hoogstraate was invited to discuss the implications of integrating Catalent’s capabilities into Novo Nordisk’s operations and what ...
Navigating the regulatory and manufacturing realities of mRNA therapeutic development
The increasingly dynamic and multifaceted landscape of mRNA therapeutics is posing new regulatory and manufacturing challenges. Both startups and established biopharma companies require innovative solutions to help them meet the ...
Innovating and collaborating to support biopharma beyond the typical CDMO
NorthX Biologics is a pioneering Swedish contract development and manufacturing organization (CDMO) that combines deep-rooted scientific heritage with cutting-edge biotechnological advancements. Headquartered in Matfors with an additional facility in Stockholm, ...
Lipum and NorthX Biologics – a deep dive into the collaboration and production process
A recent article in BioStock details how Lipum has begun the manufacturing process of SOL-116 for Phase II studies, in partnership with NorthX Biologics, a leading manufacturer of advanced biological ...
The evolving role of CDMOs in advanced biologics manufacturing
The pharmaceutical and biotech industries are experiencing a paradigm shift that is redefining the roles and responsibilities of Contract Development and Manufacturing Organizations (CDMOs). Over the past few decades, these ...